Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience

Table 2 Intra- and peri-operative parameters

Anaesthesia time; minutes	715 (370–1135)
Additional thoracic epidural anaesthesia	45
Advanced hemodynamic monitoring
PiCCO	48
Pulmonary artery catheter	3
Both	1
Anaesthesia maintenance
Propofol	37
Sevoflurane	17
Desflurane	3
Cumulative fentanyl dose; mg	1.2 (0.2-4.0)
Effective operation time; minutes	550 (255–995)
Length of CRS; minutes	340 (95–790)
Length of HIPEC, minutes	90 (60–115)
Length of reconstruction; minutes	119 (40–237)
Intraperitoneal chemotherapy (mg m⁻²)
Doxorubicin and mitomycin (15 and 15)	49
Doxorubicin and cisplatin (15 and 50)	6
Cisplatin and mitomycin (17 and 10)¹	2
Transfer to ICU	53
Length of ICU stay; days	2 (1–35)
Postoperative ventilation	33
Length of postoperative ventilation; hours²	4 (1–10)
Hospital stay; days	17 (9–259)

Data presented as median (range) or numbers (n).
CRS, Cytoreductive surgery; HIPEC, hyperthermic intraperitoneal chemotherapy.
Hemodynamic monitoring: PiCCO (Pulsion Medical Systems, Munich, Germany); Pulmonary artery catheter (Swan-Ganz CCOmbo, Edwards Life Sciences, Unterschleissheim, Germany).
¹Reduced dose of cisplatin was given in n = 2 patients.
²Data missing in n = 6 patients.

ISSN: 1477-7819